Life Biosciences
PrivateLast Round
Series D
Apr 8, 2026
Est. Valuation
$500M
Total Funding Raised
$212M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Life Biosciences is a biotechnology company that develops drug therapies aimed at enhancing the quality of life for aging individuals by addressing the systemic health decline associated with aging and combating age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Life Biosciences Comparables
Compare Life Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NewLimit | 85% | |
| Cambrian Bio | 81% | |
| Turn Biotechnologies | 81% |
Life Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Apr 8, 2026 | ||||
| Series C | Jan 5, 2022 | ||||
| Series B | Jan 15, 2019 |
Life Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Longevity Fund | Series C |
| McKenny-McFarlane Capital | Series C |
| The Venture Collective | Series C |
| Alpha Wave Global | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 154% MoM, reaching 47.8K.
- Apr 16, 2026
Monthly visitors grew 92% MoM.
Recent news
Latest coverage and updates
- hiresAug 10, 2026
Life Biosciences, Inc. hired Stephen Webster as Board of Directors on Aug 1st '26.
Life Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Life Biosciences's valuation, stock price, and market status.
Is Life Biosciences a public or private company?
Life Biosciences is a private company.
What is the current stock price of Life Biosciences?
Life Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Life Biosciences worth (valuation)?
Valuation information for Life Biosciences is not publicly available.
Can I buy Life Biosciences stock?
Life Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Life Biosciences's last funding round?
Life Biosciences's most recent funding round was Series D on April 8, 2026.
Who are the main investors in Life Biosciences?
Key investors in Life Biosciences include Alpha Wave Global.
Will Life Biosciences IPO soon?
No public IPO plans have been announced for Life Biosciences.
How can I track Life Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Life Biosciences's secondary market activity and sign up for updates.